stock
CNSP · CNS Pharmaceuticals, Inc.
What CNS Pharmaceuticals, Inc. reports to the SEC, read from its filings.
Open in the appPrice
The live CNSP price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on CNSP.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 1,461,449 as of 2026-08-11 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- —
- Net
- —
Returns
- ROE
- -4.8%
- ROA
- -3.9%
Health
- Current ratio
- 5.9x
- Debt/equity
- —
Deep value
- NCAV
- $18.18M
- NCAV per share
- $12.44
- Price/NCAV
- Locked
- NNWC
- $16.25M
- NNWC per share
- $11.12
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue (not reported by this company) | Gross profit (not reported by this company) | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$2.70M | -$2.59M | 10-Q filed 2026-08-12 |
| 2026-03-31 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$4.98M | -$4.94M | 10-Q filed 2026-08-12 Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-12-31 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$5.99M | $9.88M | DEF 14A filed 2026-08-21 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-09-30 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$3.25M | -$3.22M | 10-Q filed 2025-11-14 |
| 2025-06-30 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$2.41M | -$2.38M | 10-Q filed 2026-08-12 |
| 2025-03-31 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$4.34M | -$4.30M | 10-Q filed 2026-08-12 Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-12-31 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$3.20M | $11.67M | DEF 14A filed 2026-08-21 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-09-30 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$5.63M | -$5.61M | 10-Q filed 2025-11-14 |
- Assets
- $21.94M
- Equity
- $18.20M
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | — | -$15.99M | -$15,987 | -$13.83M |
| 2024-12-31 | — | -$14.90M | -$14,858 | -$17.12M |
| 2023-12-31 | — | -$18.87M | -$18,851 | -$14.14M |
| 2022-12-31 | — | -$15.27M | -$15.27M | -$10.56M |
| 2021-12-31 | — | -$14.49M | -$14.50M | -$13.54M |
| 2020-12-31 | — | -$9.45M | -$9.46M | -$7.34M |
| 2019-12-31 | — | -$3.83M | -$3.88M | -$3.57M |
| 2018-12-31 | — | -$881,787 | -$7.39M | -$716,385 |
Company filings
since Tue May 19 · 1 offering filing in 12 months
events
Executive or director change, Shareholder vote results
Executive or director changeShareholder vote resultsOct 28-KRegulation FD disclosure
Regulation FD disclosureJul 28-KMaterial agreement, Unregistered share sale, Executive or director change
Material agreementUnregistered share saleExecutive or director changeMay 48-KRegulation FD disclosure
Regulation FD disclosureMar 118-KExecutive or director change
Executive or director changeMar 28-KExecutive or director change
Executive or director changeFeb 178-K
5% owners ()
Ikarian Capital, LLC
Stake update
Stonepine Capital Management, LLC
Stake update
Ikarian Capital, LLC
Passive stake
Stonepine Capital Management, LLC
Stake update
Armistice Capital, LLC
Stake update
Insiders, politicians and funds
Insider trades, last 90 days
Couldn’t load insider trades
This read is unavailable. Try it again without changing anything on the page.
Politician trades, last 90 days
Couldn’t load politician trades
This read is unavailable. Try it again without changing anything on the page.
Funds
Couldn’t load funds
This read is unavailable. Try it again without changing anything on the page.
News
Stories that named CNSP, and the market events around them.
Sign in to see thisBoard
The CNSP board could not be loaded.
Retry the CNSP boardnakagai
Signals on CNSP come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the CNSP board